Another cytokine, HGF, was also measured; HGF levels were higher in patients than in HD at the baseline, but in contrast to CCL2, the levels of HGF are not associated to tumor burden and showed reduction by the treatment (Supplementary Figure S3CDE). This evidence concerns the gene HGF and neoplasm.